Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 66
Filter
Add more filters

Complementary Medicines
Publication year range
1.
Molecules ; 26(17)2021 Sep 06.
Article in English | MEDLINE | ID: mdl-34500838

ABSTRACT

Phenolic acids comprise a class of phytochemical compounds that can be extracted from various plant sources and are well known for their antioxidant and anti-inflammatory properties. A few of the most common naturally occurring phenolic acids (i.e., caffeic, carnosic, ferulic, gallic, p-coumaric, rosmarinic, vanillic) have been identified as ingredients of edible botanicals (thyme, oregano, rosemary, sage, mint, etc.). Over the last decade, clinical research has focused on a number of in vitro (in human cells) and in vivo (animal) studies aimed at exploring the health protective effects of phenolic acids against the most severe human diseases. In this review paper, the authors first report on the main structural features of phenolic acids, their most important natural sources and their extraction techniques. Subsequently, the main target of this analysis is to provide an overview of the most recent clinical studies on phenolic acids that investigate their health effects against a range of severe pathologic conditions (e.g., cancer, cardiovascular diseases, hepatotoxicity, neurotoxicity, and viral infections-including coronaviruses-based ones).


Subject(s)
Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology , Cinnamates/pharmacology , Hydroxybenzoates/pharmacology , Plant Extracts/pharmacology , Anti-Inflammatory Agents/therapeutic use , Antioxidants/therapeutic use , Cardiovascular Diseases/diagnosis , Cardiovascular Diseases/drug therapy , Cinnamates/therapeutic use , Clinical Trials as Topic , Coronavirus Infections/diagnosis , Coronavirus Infections/drug therapy , Humans , Hydroxybenzoates/therapeutic use , Liver Diseases/diagnosis , Liver Diseases/drug therapy , Neoplasms/diagnosis , Neoplasms/drug therapy , Nervous System Diseases/diagnosis , Nervous System Diseases/drug therapy , Plant Extracts/therapeutic use , Severity of Illness Index , Treatment Outcome
2.
Int J Mol Sci ; 22(4)2021 Feb 20.
Article in English | MEDLINE | ID: mdl-33672606

ABSTRACT

Oxidative stress, mitochondrial dysfunction, and neuroinflammation are strongly associated with the pathogenesis of Parkinson's disease (PD), which suggests that anti-oxidative and anti-inflammatory compounds might provide an alternative treatment for PD. Here, we evaluated the neuroprotective effects of evernic aid (EA), which was screened from a lichen library provided by the Korean Lichen Research Institute at Sunchon National University. EA is a secondary metabolite generated by lichens, including Ramalina, Evernia, and Hypogymnia, and several studies have described its anticancer, antifungal, and antimicrobial effects. However, the neuroprotective effects of EA have not been studied. We found that EA protected primary cultured neurons against 1-methyl-4-phenylpyridium (MPP+)-induced cell death, mitochondrial dysfunction, and oxidative stress, and effectively reduced MPP+-induced astroglial activation by inhibiting the NF-κB pathway. In vivo, EA ameliorated MPTP-induced motor dysfunction, dopaminergic neuronal loss, and neuroinflammation in the nigrostriatal pathway in C57BL/6 mice. Taken together, our findings demonstrate that EA has neuroprotective and anti-inflammatory effects in PD models and suggest that EA is a potential therapeutic candidate for PD.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Hydroxybenzoates/therapeutic use , Neuroprotective Agents/therapeutic use , Parkinson Disease/drug therapy , 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine , Animals , Anti-Inflammatory Agents/pharmacology , Apoptosis/drug effects , Astrocytes/drug effects , Astrocytes/metabolism , Astrocytes/pathology , Cells, Cultured , Disease Models, Animal , Dopaminergic Neurons/drug effects , Dopaminergic Neurons/metabolism , Dopaminergic Neurons/pathology , Drug Evaluation, Preclinical , Hydroxybenzoates/chemistry , Hydroxybenzoates/pharmacology , Lichens/chemistry , Male , Mice, Inbred C57BL , Mitochondria/drug effects , Mitochondria/metabolism , Motor Activity/drug effects , NF-kappa B/metabolism , Neuroprotective Agents/pharmacology , Oxidative Stress/drug effects , Parkinson Disease/pathology , Parkinson Disease/physiopathology , Signal Transduction/drug effects
3.
J Ethnopharmacol ; 269: 113737, 2021 Apr 06.
Article in English | MEDLINE | ID: mdl-33359855

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Uapaca species including Uapacastaudtii Pax (Phyllanthaceae) are used in West Africa ethnomedicine to treat diverse ailments including pile, rheumatism, oedema and wound healing. However, the anti-inflammatory and analgesic potential as well as constituents of the Uapacastaudtii stem bark has not been investigated. AIM OF THE STUDY: The study was designed to evaluate the anti-inflammatory, analgesic, and antioxidant activities of extract and fractions ofU. staudtii stem bark, and to isolate the bioactive constituents. MATERIALS AND METHODS: The anti-inflammatory, analgesic and antioxidant activities of the ethanol extract, dichloromethane, ethyl acetate, butanol, and aqueous fractions of U. staudtii stem bark, as well as protocatechuic acid and betulinic acid isolated from the bioactive ethyl acetate fraction were evaluated in different mice models of inflammation and pain; furthermore, antioxidant assays were carried out. Chemical structures of isolated compounds were established based on spectroscopic studies and comparison with literature data. RESULTS: The ethanol extract and ethyl acetate fraction exhibited good anti-inflammatory, analgesic, and antioxidant capacity in all studied models, comparable with those of the standard drugs used. Protocatechuic acid also gave significant (p < 0.05) anti-inflammatory (83%and 88% inhibition for egg-albumin induced and xylene induced oedema, respectively), analgesic (56% inhibition and 22 s of pain suppression for acetic acid-induced and hot plate-induced pain, respectively), and antioxidant effects (97% inhibition and absorbance of 2.516 at 100 µg/mL for DPPH and FRAP assay, respectively) in all the models, whereas betulinic acid only exhibited significant (p < 0.05) anti-inflammatory and antioxidant activity. CONCLUSIONS: The result supports the medicinal uses of the U. staudtii stem bark in the management of pain and inflammatory disease. This is the first report on the biological activities and characterization of compounds inU. staudtii, and presence of protocatechuic acid in Uapaca genus.


Subject(s)
Analgesics/pharmacology , Anti-Inflammatory Agents/pharmacology , Inflammation/drug therapy , Pain/drug therapy , Phyllanthus/chemistry , Plant Extracts/chemistry , Plant Extracts/pharmacology , Africa, Western , Analgesics/chemistry , Analgesics/isolation & purification , Analgesics/therapeutic use , Animals , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/isolation & purification , Anti-Inflammatory Agents/therapeutic use , Antioxidants/chemistry , Antioxidants/isolation & purification , Antioxidants/pharmacology , Antioxidants/therapeutic use , Behavior, Animal/drug effects , Disease Models, Animal , Edema/chemically induced , Edema/drug therapy , Female , Free Radical Scavengers/pharmacology , Hydroxybenzoates/isolation & purification , Hydroxybenzoates/pharmacology , Hydroxybenzoates/therapeutic use , Inflammation/etiology , Male , Mice , Pain/etiology , Pentacyclic Triterpenes/isolation & purification , Pentacyclic Triterpenes/pharmacology , Pentacyclic Triterpenes/therapeutic use , Phenol/analysis , Phenol/chemistry , Plant Bark/chemistry , Plant Extracts/isolation & purification , Plant Extracts/therapeutic use , Betulinic Acid
4.
Int. j. morphol ; 38(5): 1330-1335, oct. 2020. tab, graf
Article in English | LILACS | ID: biblio-1134444

ABSTRACT

SUMMARY: The aim of this study is to investigate the effects of Protocatechuic acid and Corchorus olitorius on streptozotocin (STZ) induced diabetic rat testis tissue. Randomly selected Wistar Albino rats were divided into five groups as; Diabetes Mellitus, Diabetes Mellitus treated with Corchorus Olitorus (STZ+CO), Diabetes Mellitus treated with Protacatechuic acid (STZ+PCA), Corchorus olitorius (CO), Protocatechuic acid (PCA) and Control. Diabetic model was generated by intraperitoneal injection of 60 mg/kg Streptozotosin. After 48 hours of the STZ injection, blood samples were collected from tail vein in order to measure blood glycose levels. Over 250 mg/dL accepted as diabetic subjets and fed with 250 mg/kg Corchorus olitorius or 20 mg/kg PCA by oral gavage for three weeks. At the end of the experiment, right testes were removed and fixed in 10 % neutral formaldehyde for paraffine embedding. Sections were stained by HE, Masson trichrome, PAS and TUNEL for microscopic evaluation. Control, PCA-only and Corchorus olitorius-only treated group testes tissues showed a normal tissue organization, when degeneration in seminiferous tubules, the vacuolization, seperations in spermatogenic cell series, outpouring of cell groups in the lumen, vesicular body formation, liquid accumulation in the interstitial region and edema were observed in STZ induced diabetic models and untreated groups. Besides, higher amount of TUNEL (+) stained cells were determined in STZ group. On the other hand, blood glucose level and number of TUNEL (+) stained cells were decreased as a result of PCA and Corchorus olitorius treatment. Because of the reduction of blood glucose level and apoptotic cell numbers, PCA and Corchorus olitorius decreace the complications of diabetes mellitus induced rat testis.


RESUMEN: El objetivo de este estudio fue investigar los efectos del ácido protocatéquico y Corchorus olitorius sobre el tejido testicular de rata diabética inducida por estreptozotocina (STZ). Las ratas Wistar Albino fueron seleccionadas al azar y se dividieron en cinco grupos; Diabetes Mellitus, Diabetes Mellitus tratada con Corchorus olitorius (STZ + CO), Diabetes Mellitus tratada con ácido protocatéquico (STZ + PCA), Corchorus olitorius (CO), ácido protocatéquico (PCA) y Control. El modelo diabético se generó por inyección intraperitoneal de 60 mg/kg de estreptozotosina. Después de 48 horas de la inyección de STZ, se recogieron muestras de sangre de la vena de la cola para medir los niveles de glucosa. Niveles mayores a 250 mg/dL fueron considerados como especímenes diabéticos y alimentados con Corchorus olitorius de 250 mg/kg o PCA de 20 mg/kg por sonda oral durante tres semanas. Al final del experimento, se extirparon los testículos derechos y se fijaron en formaldehído neutro al 10 % para la inclusión en parafina. Las secciones se tiñeron con HE, tricromo de Masson, PAS y TUNEL para evaluación microscópica. Los tejidos de los testículos de los grupos control, tratados solo con PCA y con Corchorus olitorius mostraron una organización tisular normal. En cambio en modelos diabéticos inducidos por STZ y grupos no tratados se observó degeneración en los túbulos seminíferos, vacuolización, separaciones en series de células espermatogénicas, efusión de grupos celulares en la luz, formación del cuerpo vesicular, acumulación de líquido en la región intersticial y edema. Además, se determinó una mayor cantidad de células teñidas con TUNEL (+) en el grupo STZ. Por otro lado, el nivel de glucosa en sangre y el número de células teñidas con TUNEL (+) disminuyeron como resultado del tratamiento con PCA y Corchorus olitorius. Debido a la reducción del nivel de glucosa en sangre y el número de células apoptóticas, se observó que PCA y Corchorus olitorius disminuyen las complicaciones de los testículos de rata inducidos por diabetes mellitus.


Subject(s)
Animals , Male , Rats , Testis/drug effects , Plant Extracts/pharmacology , Corchorus/chemistry , Diabetes Mellitus, Experimental/drug therapy , Hydroxybenzoates/pharmacology , Seminiferous Tubules/drug effects , Blood Glucose/analysis , Plant Extracts/therapeutic use , Rats, Wistar , Hydroxybenzoates/therapeutic use
5.
Inflamm Res ; 69(10): 1027-1037, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32671438

ABSTRACT

OBJECTIVE AND DESIGN: To clarify the effects of dietary supplementation of protocatechuic acid (PCA) and in-depth mechanisms on allergic asthma in ovalbumin (OVA)-induced mice. MATERIALS: Female BALB/c mice were randomly divided into three groups (n = 10 in each group): control group, OVA-induced allergic asthma group, and OVA plus PCA group. TREATMENT: Dietary supplementation of PCA was achieved by adding 50 mg/kg PCA to AIN 93G diet for 25 days. METHODS: Peripheral blood cells, pulmonary inflammatory cell infiltration, the levels of IL-4, IL-5, and IL-13 in bronchoalveolar lavage fluid (BALF), the mRNA levels of Th2-related genes in the lungs, and the protein expressions of the IL-4Rα-STAT6 and the Jagged1/Jagged2-Notch1/Notch2 signaling pathways were measured. RESULTS: Significantly reduced inflammatory cells infiltration and mucosal hypersecretion in the lung tissues, repaired levels of interleukin IL-4, IL-5, and IL-13 in the BALF, and decreased mRNA expression of IL-4, IL-5, and GATA3 were observed in OVA plus PCA group. Moreover, PCA treatment down-regulated the protein levels of IL-4Rα-STAT6 and Jagged1/Jagged2-Notch1/Notch2 signaling pathways. CONCLUSIONS: Dietary supplement of PCA alleviated allergic asthma partly through suppressing the IL-4Rα-STAT6 and Jagged1/Jagged2-Notch1/Notch2 signaling pathways in mice. Our study provided the theoretic basis of PCA used as functional food in preventing allergic asthma.


Subject(s)
Asthma/diet therapy , Dietary Supplements , Hydroxybenzoates/therapeutic use , Allergens , Animals , Asthma/genetics , Asthma/immunology , Asthma/pathology , Bronchoalveolar Lavage Fluid/immunology , Cytokines/genetics , Cytokines/immunology , Female , Functional Food , Jagged-1 Protein/immunology , Jagged-2 Protein/immunology , Leukocyte Count , Lung/immunology , Lung/pathology , Mice, Inbred BALB C , Ovalbumin , Receptor, Notch1/immunology , Receptor, Notch2/immunology , Receptors, Cell Surface/immunology , STAT6 Transcription Factor/immunology , Signal Transduction
6.
Nutrients ; 12(6)2020 Jun 06.
Article in English | MEDLINE | ID: mdl-32517233

ABSTRACT

Contact hypersensitivity (CHS) is the most common occupational dermatological disease. Dendritic cells (DCs) mediate the sensitization stage of CHS, while T-cells facilitate the effector mechanisms that drive CHS. Black raspberry (Rubus occidentalis, BRB) and BRB phytochemicals possess immunomodulatory properties, but their dietary effects on CHS are unknown. We examined the effects of diets containing BRB and protocatechuic acid (PCA, a constituent of BRB and an anthocyanin metabolite produced largely by gut microbes), on CHS, using a model induced by 2,4-dinitrofluorobenze (DNFB). Mice were fed control diet or diets supplemented with BRB or PCA. In vitro bone-marrow derived DCs and RAW264.7 macrophages were treated with BRB extract and PCA. Mice fed BRB or PCA supplemented diets displayed decreased DNFB-induced ear swelling, marked by decreased splenic DC accumulation. BRB extract diminished DC maturation associated with reduced Cd80 expression and Interleukin (IL)-12 secretion, and PCA reduced IL-12. Dietary supplementation with BRB and PCA induced differential decreases in IL-12-driven CHS mediators, including Interferon (IFN)-γ and IL-17 production by T-cells. BRB extracts and PCA directly attenuated CHS-promoting macrophage activity mediated by nitric oxide and IL-12. Our results demonstrate that BRB and PCA mitigate CHS pathology, providing a rationale for CHS alleviation via dietary supplementation with BRB or BRB derived anthocyanins.


Subject(s)
Dendritic Cells/immunology , Dermatitis, Contact/immunology , Dermatitis, Contact/therapy , Dietary Supplements , Dinitrofluorobenzene/adverse effects , Hydroxybenzoates/pharmacology , Hydroxybenzoates/therapeutic use , Phytotherapy , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Rubus , Animals , B7-1 Antigen/metabolism , Dermatitis, Contact/etiology , Dermatitis, Contact/metabolism , Disease Models, Animal , Interferon-gamma/metabolism , Interleukin-12/metabolism , Interleukin-17/metabolism , Mice , Mice, Inbred BALB C , RAW 264.7 Cells , T-Lymphocytes/immunology
7.
J Pharmacol Sci ; 143(3): 165-175, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32387002

ABSTRACT

yeyachun and danshen exist as Chinese patent medicine, Xuemai Tong, and are clearly effective at alleviating liver fibrosis (LF). Previous studies have indicated that triterpenoids from yeyachun (EFT), and phenolic acids from danshen (SMP) are effective in the treatment of LF. The regulation of intestinal flora is an effective method for treating LF. The aim of this study was to investigate the effect of a mixture of EFT and SMP on carbon tetrachloride (CCl4) induced LF. Our results showed the mixture significantly decreased liver damage and fibrosis index, and maintained liver tissue composition, compared to the model group. Moreover, the imbalance of symptoms of intestinal flora was improved. The mixture also caused changes to metabolites of gut flora. Furthermore, the expression of CD68 in liver tissues from the treated groups was significantly decreased when compared to the model group. However, no significant difference was observed from microstructure of gut tissues and LPS concentrations in the serum between mixture treated mice and model mice. This study suggests that the mixture of EFT and SMP had a significant effect on CCl4 induced LF, and the mechanism of this action, at least in part, involved the regulation of intestinal flora and their metabolites.


Subject(s)
Carbon Tetrachloride/adverse effects , Drugs, Chinese Herbal/pharmacology , Drugs, Chinese Herbal/therapeutic use , Gastrointestinal Microbiome/drug effects , Hydroxybenzoates/pharmacology , Hydroxybenzoates/therapeutic use , Liver Cirrhosis/drug therapy , Liver Cirrhosis/microbiology , Phytotherapy , Salvia miltiorrhiza/chemistry , Triterpenes/pharmacology , Triterpenes/therapeutic use , Animals , Antigens, CD/metabolism , Antigens, Differentiation, Myelomonocytic/metabolism , Disease Models, Animal , Drugs, Chinese Herbal/isolation & purification , Liver/metabolism , Liver Cirrhosis/chemically induced , Liver Cirrhosis/metabolism , Male , Mice, Inbred ICR , Triterpenes/isolation & purification
8.
Phytother Res ; 34(10): 2518-2533, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32307775

ABSTRACT

Fruits of Terminalia chebula Retz. (Combretaceae) are widely used as crude drugs in various traditional medicine systems. The aim of this article is to review the available scientific information regarding the traditional uses, bioactive chemical constituents and the pharmacological activities of T. chebula. Numerous researches conducted on T. chebula have confirmed the presence of wide range of the phytochemicals such as flavonoids, tannins, phenolic acids and other bioactive compounds. T. chebula is also widely studied regarding its pharmacological activities such as antioxidant, hepatoprotective, neuroprotective, cytotoxic, antidiabetic, anti-inflammatory activities among others. However, more in vivo and clinical studies for mechanism-based pharmacological evaluation should be conducted in future to provide stronger scientific evidences for their traditional uses.


Subject(s)
Fruit/physiology , Medicine, Traditional/methods , Phytochemicals , Terminalia/physiology , Animals , Antioxidants/isolation & purification , Antioxidants/therapeutic use , Flavonoids/isolation & purification , Flavonoids/therapeutic use , Fruit/chemistry , Humans , Hydroxybenzoates/isolation & purification , Hydroxybenzoates/therapeutic use , Phytochemicals/chemistry , Phytochemicals/isolation & purification , Phytochemicals/pharmacology , Phytochemicals/therapeutic use , Phytotherapy/methods , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Tannins/isolation & purification , Tannins/therapeutic use , Terminalia/chemistry
9.
Sci Transl Med ; 11(515)2019 10 23.
Article in English | MEDLINE | ID: mdl-31645456

ABSTRACT

Cell-based therapies are recognized as the next frontier in medicine, but the translation of many promising technologies into the clinic is currently limited by a lack of remote-control inducers that are safe and can be tightly regulated. Here, we developed therapeutically active engineered cells regulated by a control system that is responsive to protocatechuic acid (PCA), a metabolite found in green tea. We constructed multiple genetic control technologies that could toggle a PCA-responsive ON/OFF switch based on a transcriptional repressor from Streptomyces coelicolor We demonstrated that PCA-controlled switches can be used for guide RNA expression-mediated control of the CRISPR-Cas9 systems for gene editing and epigenetic remodeling. We showed how these technologies could be used as implantable biocomputers in live mice to perform complex logic computations that integrated signals from multiple food metabolites. Last, we used our system to treat type 1 and type 2 diabetes in mice and cynomolgus monkeys. This biocompatible and versatile food phenolic acid-controlled transgenic device opens opportunities for dynamic interventions in gene- and cell-based precision medicine.


Subject(s)
Diabetes Mellitus, Type 1/drug therapy , Diabetes Mellitus, Type 2/drug therapy , Hydroxybenzoates/therapeutic use , Tea/chemistry , Administration, Oral , Animals , Diabetes Mellitus, Type 1/metabolism , Diabetes Mellitus, Type 2/metabolism , Female , HEK293 Cells , Haplorhini , Humans , Hydroxybenzoates/administration & dosage , Hydroxybenzoates/chemistry , Male , Mice , Placenta/drug effects , Placenta/metabolism , Pregnancy , Synthetic Biology
10.
Oxid Med Cell Longev ; 2019: 3527809, 2019.
Article in English | MEDLINE | ID: mdl-31428222

ABSTRACT

Alcohol abuse has become common worldwide and has been recognized as a major cause of chronic alcoholic liver disease (ALD). ALD encompasses a complex process that includes a broad scope of hepatic lesions, ranging from steatosis to cirrhosis. In particular, reactive oxygen species (ROS) are mainly involved. Numerous studies have shown that p66shc plays a significant role in ALD. Protocatechuic acid (PCA), a dihydroxybenzoic acid that is naturally found in green tea, vegetables, and fruits, has efficient free radical scavenging effects. In this study, we aimed to assess the protective effect of PCA on ALD and to evaluate the microRNA- (miRNA-) p66shc-mediated reduction of ROS formation in ALD. Our results demonstrated that PCA treatment significantly decreased p66shc expression and downstream ROS formation in ALD. miR-219a-5p, which was identified by bioinformatics and experimental analysis, was enhanced by PCA and subsequently suppressed p66shc expression. Importantly, p66shc played an essential role in the protection of PCA-stimulated miR-219a-5p overexpression. Overall, these findings show that PCA-stimulated miR-219a-5p expression mitigates ALD by reducing p66shc-mediated ROS formation. This study may contribute to the development of therapeutic interventions for ALD.


Subject(s)
Hydroxybenzoates/pharmacology , Liver Diseases, Alcoholic/drug therapy , MicroRNAs/metabolism , Protective Agents/therapeutic use , Src Homology 2 Domain-Containing, Transforming Protein 1/metabolism , 3' Untranslated Regions , Animals , Cell Survival/drug effects , Down-Regulation/drug effects , Ethanol/toxicity , Glutathione/metabolism , Hepatocytes/cytology , Hepatocytes/drug effects , Hepatocytes/metabolism , Hydroxybenzoates/therapeutic use , Liver/drug effects , Liver/metabolism , Liver/pathology , Liver Diseases, Alcoholic/metabolism , Liver Diseases, Alcoholic/pathology , Male , Mice , MicroRNAs/chemistry , Protective Agents/pharmacology , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism , Signal Transduction/drug effects , Src Homology 2 Domain-Containing, Transforming Protein 1/chemistry , Src Homology 2 Domain-Containing, Transforming Protein 1/genetics , Superoxide Dismutase/metabolism
11.
Phytother Res ; 33(9): 2440-2447, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31318113

ABSTRACT

Cardiac fibrosis plays a crucial role in the pathogenesis of myocardial infarction (MI). It has been found that differentiation of cardiac fibroblasts (CFs) into myofibroblasts is a major event in the process of cardiac fibrosis. In the present study, we aimed to investigate the effects of protocatechuic acid (PCA), a cardiac protective agent, on the CFs differentiation in vitro. The results showed that PCA exhibited inhibitory effects on the cell proliferation and migration in angiotensin II (Ang II)-induced CFs. PCA treatment suppressed the Ang II-induced expression of α-smooth muscle actin (α-SMA), which is a hallmark of myofibroblasts. In addition, the production of extracellular matrix (ECM) proteins, including type I collagen (Col I) and connective tissue growth factor (CTGF), were significantly decreased in the PCA-treated CFs. The Ang II-induced increased levels of matrix metalloproteinase (MMP)-2, and MMP-9 were reduced by PCA. Furthermore, PCA resulted in decrease in reactive oxygen species (ROS) generation, as well as the expressions of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase enzyme 4 (NOX4) and p-p38 in Ang II-induced CFs. These findings showed that PCA treatment prevented the Ang II-induced cardiac fibrosis by inhibiting the NOX4/ROS/p38 signaling pathway in vitro, suggesting that PCA might be a therapeutic agent for MI.


Subject(s)
Angiotensin II/metabolism , Fibrosis/drug therapy , Hydroxybenzoates/therapeutic use , Myocardial Infarction/pathology , Myofibroblasts/drug effects , Reactive Oxygen Species/metabolism , p38 Mitogen-Activated Protein Kinases/metabolism , Animals , Cell Differentiation , Cell Proliferation , Cells, Cultured , Hydroxybenzoates/pharmacology , Signal Transduction/drug effects
12.
Neurochem Int ; 128: 206-214, 2019 09.
Article in English | MEDLINE | ID: mdl-31077758

ABSTRACT

We have recently demonstrated that the hydroethanolic extracts of Impatiens glandulifera Royle (Balsaminaceae) have antianxiety effect in mice. The present study was aimed to investigate an antidepressant activity of hyperoside (HYP) and protocatechuic acid (PCA), two polyphenols isolated from the aerial parts of this plant, using the forced swimming test (FST) and tail suspension test (TST) in mice. The implication of the monoaminergic system in this effect was assessed and brain-derived neurotrophic factor (BDNF) expression was measured. At doses 1.875, 3.75 and 7.5 mg/kg, HYP and PCA significantly reduced immobility in the FST and TST, without affecting locomotor activity of mice. Pretreatment with p-chlorophenylalanine (PCPA 100 mg/kg, a serotonin synthesis inhibitor) or α-methyl-DL-tyrosine (AMPT 100 mg/kg, a catecholamine synthesis inhibitor) was able to prevent antidepressant-like effect of HYP and PCA (3.75 mg/kg). Sub-effective doses of fluoxetine (5 mg/kg) or reboxetine (2 mg/kg) were capable of potentiating the effect of a sub-effective dose of HYP (0.94 mg/kg) in the FST. Co-administration of sub-effective dose of PCA (0.94 mg/kg) and reboxetine (2 mg/kg) resulted in reducing immobility in the FST. The antidepressant-like effect of HYP and PCA was also prevented by the administration of sulpiride (50 mg/kg), a D2 antagonist. In addition, HYP (3.75 and 7.5 mg/kg) and PCA (7.5 mg/kg) improved the expression of hippocampal BDNF of mice subjected to TST. Altogether, our findings suggest that HYP and PCA exert antidepressant-like effects in mice, which was possibly mediated by monoaminergic system and the upregulation of BDNF level.


Subject(s)
Antidepressive Agents/therapeutic use , Brain-Derived Neurotrophic Factor/biosynthesis , Depression/metabolism , Hydroxybenzoates/therapeutic use , Impatiens , Quercetin/analogs & derivatives , Animals , Antidepressive Agents/isolation & purification , Antidepressive Agents/pharmacology , Biogenic Amines/biosynthesis , Depression/drug therapy , Depression/psychology , Dose-Response Relationship, Drug , Hydroxybenzoates/isolation & purification , Hydroxybenzoates/pharmacology , Male , Mice , Plant Components, Aerial , Plant Extracts/isolation & purification , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Quercetin/isolation & purification , Quercetin/pharmacology , Quercetin/therapeutic use , Swimming/psychology
13.
Pak J Pharm Sci ; 31(6 (Supplementary): 2667-2672, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30587477

ABSTRACT

The increasing risk of variety of fatal diseases including diabetes mellitus is imposing serious challenge to chemist, biologists and clinicians. Due to the side effects of the chemotherapy, worldwide it is thinking that phyto-medicine are more effective to cope continuously increasing risk of fatal diseases without any side effect. Seed priming is a strategic pre-sowing semi-bioengineering technique which has ability to improve the growth rate and biologically active compounds in short time. Among seed priming techniques, tyrosine seed priming most frequently used because amino acids provide best growth media for nutritional food crops. Seeds of Momordica charantia were subjected to the pre-sowing tyrosine solution. Different growth parameters including growth emergence rate, seedling vigor, growth and weight of root, shoot and leaf were studied. The results showed positive effect on Momordica charantia seed growth and phenolic acids production i.e. ferulic acid - 43.95 ppm and sinapic acid - 18.39 ppm. The antiglycation assay showed 23.45±1.23% antiglycation activity of primed-seed fruit extract as compare to control seed fruit extract (0.87±0.03%). On the basis of the results, it is concluded that tyrosine primed seed fruit extract could effectively be further tested for pre-clinical and clinical studies to manage diabetes mellitus disease.


Subject(s)
Diabetes Mellitus , Fruit , Hydroxybenzoates/isolation & purification , Hypoglycemic Agents/isolation & purification , Momordica charantia , Tyrosine/pharmacology , Diabetes Mellitus/drug therapy , Diabetes Mellitus/metabolism , Fruit/drug effects , Humans , Hydroxybenzoates/therapeutic use , Hypoglycemic Agents/therapeutic use , Momordica charantia/drug effects , Plant Extracts/isolation & purification , Plant Extracts/therapeutic use , Plant Leaves/drug effects , Seeds/drug effects , Spectrophotometry, Ultraviolet/methods
14.
J Immunol Res ; 2018: 5429543, 2018.
Article in English | MEDLINE | ID: mdl-30356413

ABSTRACT

Propolis is an important bee product which has been applied to the treatment of several diseases. The aim of this study was to understand the material basis of Chinese propolis on pain relief; different Chinese propolis fractions (40W, 40E, 70E, and 95E raw propolis extracted followed by 40%, 70%, or 95% ethanol) were prepared, and their antinociceptive effects were evaluated. By analyzing using UPLC-Q-TOF-MS, we showed that 40W was rich in phenolic acids, like caffeic acid, while 40E, 70E, and 95E have relatively high levels in flavonoids, like galangin, pinocembrin, and chrysin. Notably, chrysin amounts in 70E and 95E are much higher than those in 40E fraction. Antinociceptive effects by these propolis fractions were evaluated in mice using acetic acid-induced writhing test, hot plate test, and tail immersion test, respectively. We noticed that only 40E fraction showed a significant reduction on acetic acid-induced writhing test. Importantly, in the hot plate test, all groups showed their effectiveness, except for the 70E group. We also noticed that 40W, 40E, and 95E administration caused an increase in the tail withdrawal latency of the mice. These data suggested that the different antinociceptive effects of different fractions from Chinese propolis extracts are directly link to their flavonoid composition.


Subject(s)
Analgesics/therapeutic use , Propolis/therapeutic use , Visceral Pain/drug therapy , Acetic Acid , Analgesics/chemistry , Animals , Caffeic Acids/chemistry , Caffeic Acids/therapeutic use , Chemical Fractionation , Chromatography, High Pressure Liquid , Flavonoids/chemistry , Flavonoids/therapeutic use , Hydroxybenzoates/chemistry , Hydroxybenzoates/therapeutic use , Male , Medicine, Chinese Traditional , Mice , Models, Animal , Propolis/chemistry
15.
J Ethnopharmacol ; 224: 335-348, 2018 Oct 05.
Article in English | MEDLINE | ID: mdl-29906537

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Sasa quelpaertensis Nakai is an edible dwarf bamboo cultivated mainly in Jeju Island, South Korea and its leaf displays various health-promoting properties including antioxidant scavenging. AIM OF THE STUDY: In this study, we aimed at elucidating its hepatoprotective effect against alcohol-induced fatty liver. METHODS: In in vitro study, we evaluated the cytotoxicity and hepatoprotective effect of different solvent fractions (aqua, butanol, chloroform, ethyl acetate and hexane) of 80% EtOH extract of S. quelpaertensis Nakai leaf. In vivo experiment performed using binge alcohol consumption model. RESULTS: Although all five fractions (0-1000 µg/mL) were non-cytotoxic to HepG2 cells, only ethyl acetate fraction (SQEA), rich in phenolic acids such as p-coumaric acid and flavonoids particularly myristin, showed hepatoprotective effect against EtOH (400 mM) in HepG2 cells. Furthermore, SQEA significantly decreased the ethanol induced cell death and enhanced the cell proliferation. In in vivo experiment using binge consumption model (5 g of EtOH/kg body weight in every 12 h for 3 times), SQEA treatment (10, 50 and 100 mg/kg) markedly reduced the alcohol induced histopathological changes and serum EtOH content, and reversed the reduction of glutathione level in ethanol challenged livers. Further, it suppressed the expression of cytochrome P450 2E1 (CYP2E1). In particular, SQEA activated AMP activated protein kinase (AMPK) pathway, and decreased the expression of tumor necrosis factor receptor-1 (TNFR1), which attenuated lipogenesis via decreased expression of fatty acid synthase (FAS). Inhibited lipogenesis due to SQEA treatment directed towards decreased perilipin-2 expression. These results indicate that SQEA has hypolipidemic effect which is mediated by decreased oxidative stress, increased fatty acid oxidation response and decreased lipogenesis. CONCLUSION: Our results suggest the possibility of developing SQEA as a natural hepatoprotective agent potent in attenuating alcohol-induced fatty liver.


Subject(s)
AMP-Activated Protein Kinases/metabolism , Fatty Liver, Alcoholic/drug therapy , Flavonoids , Hydroxybenzoates , Protective Agents , Sasa , Animals , Apoptosis/drug effects , Cell Survival/drug effects , Cytochrome P-450 CYP2E1/metabolism , Fatty Liver, Alcoholic/metabolism , Flavonoids/pharmacology , Flavonoids/therapeutic use , Glutathione/metabolism , Hep G2 Cells , Humans , Hydroxybenzoates/pharmacology , Hydroxybenzoates/therapeutic use , Liver/drug effects , Liver/pathology , Mice, Inbred C57BL , Perilipin-2/metabolism , Phytotherapy , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Plant Leaves , Protective Agents/pharmacology , Protective Agents/therapeutic use , Thiobarbituric Acid Reactive Substances/metabolism , Triglycerides/metabolism
16.
Int J Mol Sci ; 19(5)2018 May 09.
Article in English | MEDLINE | ID: mdl-29747437

ABSTRACT

Global cerebral ischemia (GCI) is one of the main causes of hippocampal neuronal death. Ischemic damage can be rescued by early blood reperfusion. However, under some circumstances reperfusion itself can trigger a cell death process that is initiated by the reintroduction of blood, followed by the production of superoxide, a blood⁻brain barrier (BBB) disruption and microglial activation. Protocatechuic acid (PCA) is a major metabolite of the antioxidant polyphenols, which have been discovered in green tea. PCA has been shown to have antioxidant effects on healthy cells and anti-proliferative effects on tumor cells. To test whether PCA can prevent ischemia-induced hippocampal neuronal death, rats were injected with PCA (30 mg/kg/day) per oral (p.o) for one week after global ischemia. To evaluate degenerating neurons, oxidative stress, microglial activation and BBB disruption, we performed Fluoro-Jade B (FJB), 4-hydroxynonenal (4HNE), CD11b, GFAP and IgG staining. In the present study, we found that PCA significantly decreased degenerating neuronal cell death, oxidative stress, microglial activation, astrocyte activation and BBB disruption compared with the vehicle-treated group after ischemia. In addition, an ischemia-induced reduction in glutathione (GSH) concentration in hippocampal neurons was recovered by PCA administration. Therefore, the administration of PCA may be further investigated as a promising tool for decreasing hippocampal neuronal death after global cerebral ischemia.


Subject(s)
Brain Ischemia/drug therapy , Hippocampus/pathology , Hydroxybenzoates/therapeutic use , Neurons/pathology , Animals , Astrocytes/drug effects , Astrocytes/metabolism , Astrocytes/pathology , Blood-Brain Barrier/drug effects , Blood-Brain Barrier/pathology , Brain Ischemia/pathology , Brain Ischemia/physiopathology , Brain Ischemia/prevention & control , Cell Death/drug effects , Cell Survival/drug effects , Cognition/drug effects , Glutathione/metabolism , Hydroxybenzoates/pharmacology , Inflammation/pathology , Intracellular Space/metabolism , Male , Microglia/drug effects , Microglia/metabolism , Microglia/pathology , Models, Biological , Neurons/drug effects , Neurons/metabolism , Oxidative Stress/drug effects , Rats, Sprague-Dawley , Zinc/metabolism
17.
Biomed Pharmacother ; 100: 147-155, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29428662

ABSTRACT

Protocatechuic acid (PCA) is a natural antioxidant with beneficial cardiovascular properties. In this study, the effect of supplementation with PCA was investigated in deoxycorticosterone acetate (DOCA)-salt hypertension. Male Wistar rats received DOCA (25 mg/kg, s.c.) twice weekly and 1% NaCl in drinking water and simultaneously treated with PCA (50, 100 and 200 mg/kg, p.o.) for 4 weeks. Systolic blood pressure (SBP) was detected using tail-cuff method. Electrolytes including Na+, K+ and chloride, catalase activity, glutathione, total antioxidant capacity, malondialdehyde (MDA) and hydroperoxides concentration were measured in serum samples. Body and organs weight, water intake and, kidney and heart histopathology were also evaluated. Administration of PCA reversed the changes caused by DOCA-salt approximately at all doses. At the lowest dose, PCA significantly decreased SBP (132.5 ±â€¯4.0 vs 152.3 ±â€¯4.5 mmHg, P < .05), serum sodium (138.5  ±â€¯1.52 vs 141 ±â€¯1.50, P < .05) and chloride level (101.6 ±â€¯1.47 vs 110 ±â€¯1.39, P < .01) and raised serum potassium level (3.8 ±â€¯0.09 vs 3.1 ±â€¯0.17, P < .05) compared with DOCA-salt hypertensive rats. PCA increased serum catalase activity, total antioxidant capacity and glutathione concentration and reduced MDA and hydroperoxides levels. PCA also improved organ weight changes, reduced water intake and moderately prevented histopathological changes of kidney and heart upon DOCA-salt administration. The present study indicates the antihypertensive and antioxidant effects of PCA against DOCA-salt hypertension.


Subject(s)
Antihypertensive Agents/therapeutic use , Antioxidants/therapeutic use , Hydroxybenzoates/therapeutic use , Hypertension/drug therapy , Animals , Antihypertensive Agents/administration & dosage , Antioxidants/administration & dosage , Blood Pressure/drug effects , Desoxycorticosterone Acetate , Disease Models, Animal , Dose-Response Relationship, Drug , Hydroxybenzoates/administration & dosage , Hypertension/metabolism , Hypertension/pathology , Kidney/drug effects , Kidney/pathology , Lipid Peroxidation/drug effects , Male , Myocardium/pathology , Rats, Wistar , Sodium Chloride
18.
Arch Physiol Biochem ; 124(5): 410-417, 2018 Dec.
Article in English | MEDLINE | ID: mdl-29260581

ABSTRACT

This study investigated the influence of caffeic, ferulic, gallic and protocatechuic acids on high-fructose diet-induced metabolic syndrome in rats. Oral administration of the phenolic acids significantly reversed high-fructose diet-mediated increase in body mass index and blood glucose. Furthermore, phenolic acids restored high-fructose diet-mediated alterations in metabolic hormones (insulin, leptin and adiponectin). Similarly, elevated tumour necrosis factor-α, interleukin-6 and -8 were significantly lowered. Administration of phenolic acids restored High-fructose diet-mediated increase in the levels of lipid parameters and indices of atherosclerosis, cardiac and cardiovascular diseases. High-fructose diet-mediated decrease in activities of antioxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase and glucose 6-phosphate dehydrogenase) and increase in oxidative stress biomarkers (reduced glutathione, lipid peroxidation products, protein oxidation and fragmented DNA) were significantly restored by the phenolic acids. The result of this study shows protective influence of caffeic acid, ferulic acid, gallic acid and protocatechuic acid in high-fructose diet-induced metabolic syndrome.


Subject(s)
Antioxidants/therapeutic use , Dietary Supplements , Dyslipidemias/prevention & control , Hyperglycemia/prevention & control , Insulin Resistance , Metabolic Syndrome/therapy , Oxidative Stress , Animals , Anti-Obesity Agents/therapeutic use , Biomarkers/blood , Caffeic Acids/therapeutic use , Coumaric Acids/therapeutic use , Cytokines/blood , Diet, Carbohydrate Loading/adverse effects , Fructose/adverse effects , Gallic Acid/therapeutic use , Humans , Hydroxybenzoates/therapeutic use , Metabolic Syndrome/etiology , Metabolic Syndrome/immunology , Metabolic Syndrome/metabolism , Obesity/prevention & control , Phenols/therapeutic use , Random Allocation , Rats, Wistar
19.
Mol Genet Metab ; 123(3): 289-291, 2018 03.
Article in English | MEDLINE | ID: mdl-29246431

ABSTRACT

Primary disorders of the human coenzyme Q10 (CoQ10) biosynthesis pathway are a known cause of severe pediatric diseases. So far, oral administration of CoQ10 is the only treatment strategy for affected individuals. However, the real benefit of CoQ10 supplementation remains questionable and clinical studies regarding efficiency are lacking. Here we provide an outlook on novel treatment approaches using CoQ precursor compounds. These metabolic bypass strategies might be a promising alternative for oral CoQ10 supplementation regimens.


Subject(s)
Ataxia/drug therapy , Hydroxybenzoates/therapeutic use , Mitochondrial Diseases/drug therapy , Muscle Weakness/drug therapy , Ubiquinone/analogs & derivatives , Ubiquinone/deficiency , Animals , Apoptosis/drug effects , Ataxia/genetics , Ataxia/pathology , Biosynthetic Pathways/drug effects , Biosynthetic Pathways/genetics , Cytochrome P-450 Enzyme System/genetics , Cytochrome P-450 Enzyme System/metabolism , Disease Models, Animal , Humans , Hydroxybenzoates/pharmacology , Mice , Mitochondria/metabolism , Mitochondrial Diseases/genetics , Mitochondrial Diseases/pathology , Muscle Weakness/genetics , Muscle Weakness/pathology , Pyrimidines/metabolism , Solubility , Treatment Outcome , Ubiquinone/biosynthesis , Ubiquinone/genetics , Ubiquinone/metabolism , Ubiquinone/therapeutic use , Vitamins/therapeutic use
20.
Curr Med Chem ; 25(39): 5347-5371, 2018.
Article in English | MEDLINE | ID: mdl-29210634

ABSTRACT

Diet is an essential factor affecting the development of and risk for diabetes mellitus. In search of preventative and therapeutic strategies, the potential role of certain foods and their bioactive compounds to prevent the pathogenesis associated with metabolic diseases is to be considered. Human consumption of anthocyanins is among the highest of all flavonoids. Epidemiological studies have suggested that the consumption of anthocyanins lowers the risk of diabetes and diabetic complications. Anthocyanins are important natural bioactive pigments responsible for red to blue colour of fruits, leaves, seeds, stems and flowers, which are present in a variety of plant species particularly in berries and cherries. A large number of bioactive anthocyanins, such as cyanidin, malvidin, delphinidin, pelargonidin, peonidin, petunidin and their metabolites have shown multiple biological activities with apparent effects on glucose absorption, glucose uptake, insulin secretion and sensitivity, on the enzymes involved in glucose metabolism, gene expressions, inflammatory mediators, glucose transporters in progression of diabetes and associated complications, such as diabetic retinopathy, nephropathy, neuropathy and diabetic vascular diseases. The versatility of the anthocyanins provides a promising approach for diabetes management than synthetic drugs. Here we summarize the effect of several anthocyanins on many in vitro, in vivo and clinical studies and also reveal the mechanisms which could prevent or reverse the underlying mechanisms of diabetic pathologies including promotion of antioxidant, antihyperlipidemic, anti-inflammatory and anti-apoptotic activities.


Subject(s)
Anthocyanins/therapeutic use , Diabetes Mellitus/prevention & control , Anthocyanins/chemistry , Anthocyanins/pharmacology , Diabetes Mellitus/pathology , Diet , Fruit/chemistry , Fruit/metabolism , Humans , Hydroxybenzoates/chemistry , Hydroxybenzoates/pharmacology , Hydroxybenzoates/therapeutic use , Oxidative Stress/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL